Kwon Young-Eun, Ahn Shin-Young, Ko Gang-Jee, Kwon Young-Joo, Kim Ji-Eun
Department of Internal Medicine, Korea University Guro Hospital, Seoul 08308, Republic of Korea.
Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.
J Clin Med. 2024 Dec 24;14(1):20. doi: 10.3390/jcm14010020.
: Uric acid levels are linked to cardiovascular outcomes and mortality, especially in chronic kidney disease (CKD). However, their impact across varying kidney function remains unclear. : We conducted a retrospective cohort study using the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) database from a single center. Adult patients with at least one serum uric acid measurement between 2002 and 2021 were included and categorized by estimated glomerular filtration rate (eGFR): normal kidney function (≥90 mL/min/1.73 m), mild dysfunction (60-89 mL/min/1.73 m), moderate dysfunction (30-59 mL/min/1.73 m), and advanced dysfunction (<30 mL/min/1.73 m). The primary outcome was all-cause mortality with secondary outcomes being myocardial infarction (MI) and heart failure (HF). : A total of 242,793 participants were analyzed. Uric acid levels showed a U-shaped association with all-cause mortality in advanced kidney dysfunction, where both low (<3 mg/dL) and high (>10 mg/dL) levels increased mortality risk. In mild kidney dysfunction, lower uric acid levels were linked to better survival. HF risk increased linearly with higher uric acid, particularly in normal kidney function, while no significant association was found between uric acid and MI in any group. : Uric acid levels are associated with mortality in a U-shaped pattern for advanced kidney dysfunction, while lower levels appear protective in mild dysfunction. These findings suggest the need for personalized uric acid management in CKD patients based on their kidney function.
尿酸水平与心血管疾病结局及死亡率相关,尤其是在慢性肾脏病(CKD)中。然而,其在不同肾功能水平中的影响仍不明确。我们使用来自单一中心的观察性医疗结局合作组织通用数据模型(OMOP-CDM)数据库进行了一项回顾性队列研究。纳入2002年至2021年间至少有一次血清尿酸测量值的成年患者,并根据估计肾小球滤过率(eGFR)进行分类:肾功能正常(≥90 mL/min/1.73 m²)、轻度功能障碍(60 - 89 mL/min/1.73 m²)、中度功能障碍(30 - 59 mL/min/1.73 m²)和重度功能障碍(<30 mL/min/1.73 m²)。主要结局是全因死亡率,次要结局是心肌梗死(MI)和心力衰竭(HF)。共分析了242,793名参与者。在重度肾功能障碍中,尿酸水平与全因死亡率呈U形关联,低水平(<3 mg/dL)和高水平(>10 mg/dL)均增加死亡风险。在轻度肾功能障碍中,较低的尿酸水平与更好的生存率相关。HF风险随尿酸水平升高呈线性增加,尤其是在肾功能正常时,而在任何组中尿酸与MI之间均未发现显著关联。对于重度肾功能障碍,尿酸水平与死亡率呈U形模式相关,而在轻度功能障碍中较低水平似乎具有保护作用。这些发现表明,需要根据CKD患者的肾功能对尿酸进行个性化管理。